BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 20159256)

  • 1. Revertant T lymphocytes in a patient with Wiskott-Aldrich syndrome: analysis of function and distribution in lymphoid organs.
    Trifari S; Scaramuzza S; Catucci M; Ponzoni M; Mollica L; Chiesa R; Cattaneo F; Lafouresse F; Calvez R; Vermi W; Medicina D; Castiello MC; Marangoni F; Bosticardo M; Doglioni C; Caniglia M; Aiuti A; Villa A; Roncarolo MG; Dupré L
    J Allergy Clin Immunol; 2010 Feb; 125(2):439-448.e8. PubMed ID: 20159256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mosaicism in the Wiskott-Aldrich syndrome: molecular and functional characterization of genotypic revertants.
    Davis BR; Yan Q; Bui JH; Felix K; Moratto D; Muul LM; Prokopishyn NL; Blaese RM; Candotti F
    Clin Immunol; 2010 Apr; 135(1):72-83. PubMed ID: 20123155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings.
    Wada T; Konno A; Schurman SH; Garabedian EK; Anderson SM; Kirby M; Nelson DL; Candotti F
    J Clin Invest; 2003 May; 111(9):1389-97. PubMed ID: 12727931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo reversion of an inherited mutation in a Chinese patient with Wiskott-Aldrich syndrome.
    Xie JW; Zhang ZY; Wu JF; Liu DW; Liu W; Zhao Y; Jiang LP; Tang XM; Wang M; Zhao XD
    Hum Immunol; 2015 Jun; 76(6):406-13. PubMed ID: 25862925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mosaicism of NK cells in a patient with Wiskott-Aldrich syndrome.
    Lutskiy MI; Beardsley DS; Rosen FS; Remold-O'Donnell E
    Blood; 2005 Oct; 106(8):2815-7. PubMed ID: 15985539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential contribution of Wiskott-Aldrich syndrome protein to selective advantage in T- and B-cell lineages.
    Konno A; Wada T; Schurman SH; Garabedian EK; Kirby M; Anderson SM; Candotti F
    Blood; 2004 Jan; 103(2):676-8. PubMed ID: 14504083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Identification of two novel WASP gene mutations in 3 boys with Wiskott-Aldrich syndrome].
    Jiang LP; Xu YH; Yang XQ; Liu EM; Wang LJ; Lau YL; Chan KW
    Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):590-3. PubMed ID: 14744380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple independent second-site mutations in two siblings with somatic mosaicism for Wiskott-Aldrich syndrome.
    Boztug K; Germeshausen M; Avedillo Díez I; Gulacsy V; Diestelhorst J; Ballmaier M; Welte K; Maródi L; Chernyshova L; Klein C
    Clin Genet; 2008 Jul; 74(1):68-74. PubMed ID: 18479478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large granular lymphocyte proliferation and revertant mosaicism: two rare events in a Wiskott-Aldrich syndrome patient.
    Boztug K; Baumann U; Ballmaier M; Webster D; Sandrock I; Jacobs R; Lion T; Preuner S; Germeshausen M; Hansen G; Welte K; Klein C
    Haematologica; 2007 Mar; 92(3):e43-5. PubMed ID: 17405757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A second-site mutation in the initiation codon of WAS (WASP) results in expansion of subsets of lymphocytes in an Wiskott-Aldrich syndrome patient.
    Du W; Kumaki S; Uchiyama T; Yachie A; Yeng Looi C; Kawai S; Minegishi M; Ramesh N; Geha RS; Sasahara Y; Tsuchiya S
    Hum Mutat; 2006 Apr; 27(4):370-5. PubMed ID: 16511828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unprecedented diversity of genotypic revertants in lymphocytes of a patient with Wiskott-Aldrich syndrome.
    Davis BR; Dicola MJ; Prokopishyn NL; Rosenberg JB; Moratto D; Muul LM; Candotti F; Michael Blaese R
    Blood; 2008 May; 111(10):5064-7. PubMed ID: 18332229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two novel mutations identified in the Wiskott-Aldrich syndrome protein gene cause Wiskott-Aldrich syndrome and thrombocytopenia.
    Andreu N; Matamoros N; Escudero A; Fillat C
    Int J Mol Med; 2007 May; 19(5):777-82. PubMed ID: 17390083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of clinical and molecular characteristics of Wiskott-Aldrich syndrome in 24 patients from 23 unrelated Chinese families.
    Zhang ZY; Xiao HQ; Jiang LP; Zhou Y; Zhao Q; Yu J; Liu W; Yang XQ; Zhao XD
    Pediatr Allergy Immunol; 2010 May; 21(3):522-32. PubMed ID: 20546529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wiskott-Aldrich Syndrome in four male siblings from a consanguineous family from Lebanon.
    Mansour R; El-Orfali Y; Saber A; Noun D; Youssef N; Youssef Y; Hanna-Wakim R; Dbaibo G; Abboud M; Massaad MJ
    Clin Immunol; 2020 Oct; 219():108573. PubMed ID: 32814211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple patients with revertant mosaicism in a single Wiskott-Aldrich syndrome family.
    Wada T; Schurman SH; Jagadeesh GJ; Garabedian EK; Nelson DL; Candotti F
    Blood; 2004 Sep; 104(5):1270-2. PubMed ID: 15142877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization in lymphocytes from patients with WAS mutations that disrupt WIP binding.
    Massaad MJ; Ramesh N; Le Bras S; Giliani S; Notarangelo LD; Al-Herz W; Notarangelo LD; Geha RS
    J Allergy Clin Immunol; 2011 Apr; 127(4):998-1005.e1-2. PubMed ID: 21376381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genotype of the original Wiskott phenotype.
    Binder V; Albert MH; Kabus M; Bertone M; Meindl A; Belohradsky BH
    N Engl J Med; 2006 Oct; 355(17):1790-3. PubMed ID: 17065640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel WASP mutation in a patient with Wiskott-Aldrich syndrome: Case report and review of the literature.
    Eghbali M; Sadeghi-Shabestari M; Najmi Varzaneh F; Zare Bidoki A; Rezaei N
    Allergol Immunopathol (Madr); 2016; 44(5):450-4. PubMed ID: 26993433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wiskott-Aldrich Syndrome causing mutation, Pro373Ser restricts conformational changes essential for WASP activity in T-cells.
    Jain N; George B; Thanabalu T
    Biochim Biophys Acta; 2014 Apr; 1842(4):623-34. PubMed ID: 24440360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.